February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Recommendations to improve using Overall Survival data to inform benefit-risk assessments – FDA Oncology
Jul 25, 2024, 08:28

Recommendations to improve using Overall Survival data to inform benefit-risk assessments – FDA Oncology

FDA Oncology posted on X about recent paper by Lisa Rodriguez et al., commenting: 

In a new Clinical Cancer Research paper, FDA’s Lisa Rodriguez, Nicole Gormley and colleagues share best practices, propose novel statistical methodologies, and provide recommendations to improve the rigor of using Overall Survival data to inform benefit-risk assessments.”

Improving Collection and Analysis of Overall Survival Data

Journal: AACR Journals

Author: Lisa R. Rodriguez, Nicole J. Gormley, Ruixiao Lu, Anup K. Amatya, George D. Demetri, Keith T. Flaherty, Ruben A. Mesa, Richard Pazdur, Mikkael A. Sekeres, Minghua Shan, Steven Snapinn, Marc R. Theoret, Rukiya Umoja, Jonathon Vallejo, Nicholas J. H. Warren, Qing Xu, Kenneth C. Anderson

Recommendations to improve using Overall Survival data to inform benefit-risk assessments - FDA Oncology

Source: FDA Oncology/X